Search results
Results from the WOW.Com Content Network
The IHS National Pharmacy and Therapeutics Committee (NPTC) is composed of administrative leaders and clinical professionals, including pharmacists and physicians, who regulate the IHS National Core Formulary (NCF) to reflect current clinical practices and literature. [42]
WHO Model Formulary 2008. World Health Organization. hdl: 10665/44053. ISBN 978-92-4-154765-9. The selection and use of essential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. 2015.
A national formulary contains a list of medicines that are approved for prescription throughout the country, indicating which products are interchangeable. It includes key information on the composition, description, selection, prescribing, dispensing and administration of medicines.
The USP is published in a combined volume with the National Formulary (a formulary) as the USP-NF. [2] If a drug ingredient or drug product has an applicable USP quality standard (in the form of a USP-NF monograph), it must conform in order to use the designation "USP" or "NF".
A national formulary is essentially a listing of available and affordable medicines that are relevant to the treatment of diseases in a particular country. It is usually a source of unbiased drug information and helps promote the rational use of safe, effective and good-quality medicines. [9]
National growth in e-prescribing over the period September 2008 through June 2012 increased over 40 percent, with individual states increasing adoption anywhere from 28 percent to 70 percent. [41] In 2019, the Federal Trade Commission sued Surescripts, alleging that the company employed unlawful restraints in order to maintain its monopolies ...
The British National Formulary is the core guide for pharmacists and clinicians. In many non-US western countries, a 'fourth hurdle' of cost effectiveness analysis has developed before new technologies can be provided.
The model list is perceived by the WHO to be an indication of a common core of medicines to cover most common needs. There is a strong emphasis on the need for national policy decisions and local ownership and implementation. In addition, a number of guiding principles for essential drug programs have emerged.